A detailed history of Jane Street Group, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 401,908 shares of CPRX stock, worth $8.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
401,908
Previous 116,344 245.45%
Holding current value
$8.5 Million
Previous $1.8 Million 343.34%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.19 - $21.35 $4.34 Million - $6.1 Million
285,564 Added 245.45%
401,908 $7.99 Million
Q2 2024

Aug 14, 2024

BUY
$14.68 - $16.92 $777,878 - $896,573
52,989 Added 83.64%
116,344 $1.8 Million
Q1 2024

May 15, 2024

SELL
$13.18 - $17.11 $383,893 - $498,362
-29,127 Reduced 31.49%
63,355 $1.01 Million
Q4 2023

Feb 14, 2024

SELL
$11.78 - $17.29 $999,356 - $1.47 Million
-84,835 Reduced 47.84%
92,482 $1.55 Million
Q3 2023

Nov 14, 2023

BUY
$11.69 - $15.02 $1 Million - $1.29 Million
85,911 Added 93.99%
177,317 $2.07 Million
Q2 2023

Aug 14, 2023

SELL
$11.5 - $18.08 $127,213 - $200,000
-11,062 Reduced 10.8%
91,406 $1.23 Million
Q1 2023

May 15, 2023

BUY
$14.34 - $21.05 $848,512 - $1.25 Million
59,171 Added 136.66%
102,468 $1.7 Million
Q4 2022

Feb 14, 2023

BUY
$12.25 - $19.5 $369,055 - $587,476
30,127 Added 228.75%
43,297 $805,000
Q3 2022

Nov 14, 2022

SELL
$7.06 - $15.52 $77,483 - $170,332
-10,975 Reduced 45.45%
13,170 $169,000
Q2 2022

Aug 16, 2022

SELL
$6.23 - $8.57 $318,508 - $438,141
-51,125 Reduced 67.92%
24,145 $169,000
Q1 2022

May 17, 2022

BUY
$5.31 - $8.31 $306,052 - $478,963
57,637 Added 326.87%
75,270 $624,000
Q4 2021

Feb 15, 2022

SELL
$5.21 - $7.45 $40,070 - $57,297
-7,691 Reduced 30.37%
17,633 $119,000
Q3 2021

Nov 16, 2021

BUY
$4.85 - $6.04 $20,913 - $26,044
4,312 Added 20.52%
25,324 $134,000
Q2 2021

Aug 16, 2021

BUY
$4.29 - $6.05 $90,141 - $127,122
21,012 New
21,012 $121,000
Q1 2021

May 18, 2021

SELL
$3.45 - $4.69 $112,656 - $153,147
-32,654 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$2.97 - $3.83 $392,182 - $505,743
-132,048 Reduced 80.17%
32,654 $109,000
Q3 2020

Nov 17, 2020

BUY
$2.97 - $5.08 $447,700 - $765,764
150,741 Added 1079.73%
164,702 $489,000
Q2 2020

Aug 17, 2020

BUY
$3.48 - $5.05 $48,584 - $70,503
13,961 New
13,961 $65,000
Q4 2019

Feb 14, 2020

SELL
$3.67 - $5.7 $90,927 - $141,223
-24,776 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.89 - $7.43 $96,378 - $184,085
24,776 New
24,776 $132,000
Q1 2018

May 15, 2018

SELL
$2.39 - $4.01 $44,740 - $75,067
-18,720 Closed
0 $0
Q4 2017

Feb 15, 2018

SELL
$2.51 - $4.4 $13,250 - $23,227
-5,279 Reduced 22.0%
18,720 $73,000
Q3 2017

Nov 14, 2017

BUY
$2.4 - $2.94 $57,597 - $70,557
23,999
23,999 $60,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.17B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.